Pathogenesis of the eosinophilic pleural effusions

Current Opinion in Pulmonary Medicine

Volumn 10, Issue 4, 2004, Pages 289-293

  Kalomenidis, Ioannis ^a   Light, Richard W ^b,c  

^a EVANGELISMOS HOSPITAL   (Greece)

^b SAINT THOMAS HOSPITAL   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Chemokines; Eosinophilic pleural effusion; IL 5; Pathogenesis

Indexed keywords

ALLERGIC DISEASE; CELL ACTIVITY; CHEMICAL ANALYSIS; DISEASE ACTIVITY; EOSINOPHIL; EOSINOPHILIA; EOSINOPHILIC PLEURAL EFFUSION; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; EXPERIMENTATION; HUMAN; HYPERSENSITIVITY REACTION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PLEURA EFFUSION; PROTEIN FUNCTION; REVIEW;

EID: 3042578372     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcp.0000127902.37822.13     Document Type: Review

References (47)

1. Kalomenidis I, Light RW: Eosinophilic pleural effusions. Curr Opin Pulmonary Med 2003, 9:254-260. In this review article, the current concept about the etiology and the clinical features of EPE were discussed. Furthermore, suggestions about how a patient with an EPE should be approached are made.
2. Zangrilli JG: Regulation of eosinophil viability by cytokines. Am J Respir Cell Mol Biol 2002, 26:388-390.
3. Nishinakamura R, Miyajima A, Mee PJ, et al.: Hematopoiesis in mice lacking the entire granulocyte-macrophage-colony-stimulating factor/interleukin-3/interleukin-5 functions. Blood 1996, 88:2458-2464.
4. Yoshida T, Ikuta K, Sugaya H, et al.: Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5Rα-deficient mice. Immunity 1996, 4:483-494.
5. Broide DH, Number D, Sriramarao P: Inhibition of eosinophil rolling and recruitment in P-selectin and intracellular adhesion molecule-1-deficient mice. Blood 1998, 91:2847-2856.
6. Robinson SD, Frenette PS, Rayburn H. et al.: Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment. Proc Natl Acad Sci U S A 1999, 96:11452-11457.
7. Rothenberg ME: Mechanisms of disease. Eosinophilia. N Engl J Med 1998, 338:1592-1600.
8. Bandeira-Melo C, Herbst A, Weller PF: Eotaxins. Contributing to the diversity of eosinophil recruitment and activation. Am J Resp Cell Mol Biol 2001, 24:653-657.
9. Rothenberg ME, Zimmermann N, Mishra A, et al.: Chemokines and chemokine receptors: their role in allergic airway diseases. J Clin Immunol 1999, 19:250-265.
10. Zlotnik A, Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
11. Wang JM, Rambaldi A, Biondi A, et al.: Recombinant human interleukin-5 is a selective eosinophil chemoattractant. Eur J Immunol 1989, 19:701-705.
12. Larbi KY, Allen AR, Tam FW, et al.: VCAM-1 has a tissue-specific role in mediating interleukin-4-induced eosinophils accumulation in rat models: evidence for a dissociation between endothelial-cell VCAM-1 expression and a functional role in eosinophil migration. Blood 2000, 96:3601-3609.
13. Wills-Karp M, Chiaramonte M: Interleukin-13 in asthma. Curr Opin Pulm Med 2003, 9:21-27. This review article discuss the biological activity of IL-13 and its role in eosinophilic inflammation with special focus in the pathogenesis of bronchial asthma.
14. Li L, Xia Y, Nguyen A, et al.: Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999, 162:2477-2487.
15. Sironi M, Sciacca FL, Matteucci C, et al.: Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 1994, 84:1913-1921.
16. Smit HJ, van den Heuvel MM, Barbierato SB, et al.: Analysis of pleural fluid in idiopathic spontaneous pneumothorax; correlation of eosinophil percentage with the duration of air in the pleural space. Respir Med 1999, 93:262-267.
17. Chapman JS, Reynolds R: Eosinophilic response to intraperitoneal blood. J Lab Clin Med 1958, 51:516-520.
18. Kalomenidis I, Guo Y, Peebles RS, et al.: Contribution of IL-5 and IL-13 in pneumothorax-associated pleural eosinophilia [abstract]. Chest 2003, 4:s81.
19. Georas SN, Beck LA, Stellato C: What is eotaxin doing in the pleura? Am J Resp Cell Mol Biol 2002, 24:384-387.
20. Matsumoto N, Mukae H, Nakamura-Uchiyama F, et al.: Elevated levels of thymus and activation-regulated chemokine (TARC) in pleural effusion samples from patients infested with Paragonimus westermani. Clin Exp Immunol 2002, 130:314-318.
21. Ali S, Kaur J, Patel KD: Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation. Am J Pathol 2000, 157:313-321.
22. Schandene L, Namias B, Crusiaux A, et al.: IL-5 in post-traumatic eosinophilic pleural effusion. Clin Exp Immunol 1993, 93:115-119.
23. Vanderlinden E, Demanet C, De Waele M, et al.: Mechanisms of eosinophilic pleural inflammation in primary spontaneous pneumothorax [abstract]. Am J Respir Crit Care Med 2002, 165:A609.
24. Taniguchi H, Mukae H, Matsumoto N, et al.: Elevated IL-5 levels in pleural fluid of patients with paragonimiasis westermani. Clin Exp Immunol 2000, 123:94-98.
25. Ishii H, Mukae H, Inoue Y, et al.: A rare case of eosinophilic pleuritis due to sparganosis. Intern Med 2001, 40:783-785.
26. Nakamura Y, Ozaki T, Kamei T, et al.: Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocyte/macrophage colony-stimulating factor, interleukin-5, and interleukin-3. Am J Respir Cell Mol Biol 1993, 8:605-611.
27. Hallden G, Hellman C, Gronneberg R, et al.: Increased levels of IL-5 positive peripheral blood eosinophils and lymphocytes in mild asthmatics after allergen inhalation provocation. Clin Exp Allergy 1999, 29:595-603.
28. Hoontrakoon R, Chu HW, Gardai SJ, et al.: Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. Am J Respir Cell Mol Biol 2002, 26:404-412.
29. Horiuchi T, Weller PF: Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 1997, 17:70-77.
30. Grove CS, Lee YC: Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med 2002, 8:294-301. A review article that discusses the current knowledge concerning the biological activities of vascular endothelial growth factor and its role in the pathogenesis of exudative pleural effusions.
31. Nishigaki Y, Fujiucni S, Yamazaki Y, et al.: Increased vascular endothelial growth factor in acute eosinophilic pneumonia. Eur Respir J 2003, 21:774-778. In this study, the authors examined the vascular endothelial growth factor (VEGF) and the IL-5 levels in bronchoalveolar lavage (BAL) in patients with acute eosinophilic pneumonia (AIP) and normal controls. They reported that the BAL levels of VEGF and the IL-5 are significantly higher in patients with AIP than in normal controls and that the BAL levels of both VEGF and the IL-5 are decreased in parallel with clinical improvement of the patients. Additionally, a significant correlation between the BAL levels of VEGF and the IL-5 was observed.
32. Kalomenidis IH, Mohamed KH, Lane KB, et al.: Pleural fluid levels of vascular cell adhesion molecule-1 are elevated in eosinophilic pleural effusions. Chest 2003, 124:159-166. A clinical study that showed that the pleural fluid levels of vascular cell adhesion molecule-1 are higher in EPEs than in non-EPEs and correlate with the pleural fluid eosinophils. In the same patients, the pleural fluid eotaxin and RANTES levels did not differ between EPEs and non-EPEs and did not correlate with the pleural fluid eosinophils.
33. Jonjic N, Peri G, Bernasconi S, et al.: Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992, 176:1165-1174.
34. Yokoyama A, Kohno N, Ito M, et al.: Eotaxin levels in pleural effusions: comparison with monocyte chemoattractant protein-1 and IL-8. Intern Med 2000, 39:547-552.
35. Kobayashi TK, Tsunasima T, Ohnishi S, et al.: The presence of mast cells in eosinophilic pleural effusions. Acta Cytol 1980, 24:84-85.
36. Beekman JF, Bosniak S, Canter HG: Eosinophilia and elevated IgE concentration in a serous pleural effusion following trauma. Am Rev Respir Dis 1974, 110:484-489.
37. Nash DR, Wallace RJ Jr: Immunoglobulin E and other immunoglobulins in patients with eosinophilic pleural effusions. J Lab Clin Med 1985, 106:512-516.
38. Lima MC, Martins MA, Perez SA, et al.: Effect of azelastine on platelet-activating factor and antigen-induced pleurisy in rats. Eur J Pharmacol 1991, 197:201-207.
39. Klein A, Talvani A, Cara DC, et al.: Stem cell factor plays a major role in the recruitment of eosinophils in allergic pleurisy in mice via the production. J Immunol 2000, 164:4271-4276.
40. Bozza PT, Castro-Faria-Neto HC, Pires AL, et al.: LPS induces eosinophil accumulation in the rat pleural cavity. Braz J Med Biol Res 1991, 24:957-960.
41. Katayama H, Yokoyama A, Kohno N, et al.: Production of eosinophilic chemokines by normal pleural mesothelial cells. Am J Respir Cell Mol Biol 2002, 26:398-403. This study shows inflammatory cytokines may regulate the production of eosinophil chemoattractants by pleural mesothelial cells. TNFa plus IL-4 induced the production of eotaxin, while TNFa plus IFN-gamma induced the production of RANTS by human pleural mesothelial cells, in vitro.
42. Klein A, Talvani A, Silva PM, et al.: Stem cell factor-induced leukotriene b(4) production cooperates with eotaxin to mediate the recruitment of eosinophils during allergic pleurisy in mice. J Immunol 2001, 167:524-531.
43. Bozza PT, Castro-Faria-Neto HC, Penido C, et al.: IL-5 accounts for the mouse pleural eosinophil accumulation triggered by antigen but not by LPS. Immunopharmacology 1994, 27:131-136.
44. Penido C, Castro-Faria-Neto HC, Vieira-de-Abreu A, et al.: LPS induces migration via CCR3 signaling through a mechanism independent of RANTES and eotaxin. Am J Respir Cell Mol Biol 2001, 25:707-716.
45. Frode-Saleh TS, Calixto JB: Synergistic anti-inflammatory effect of NF-κB inhibitors and steroidal or non steroidal anti-inflammatory drugs in the pleural inflammation induced by carrageenan in mice. Inflamm Res 2000, 49:330-337.
46. Pasquale CP, Martins MA, Bozza PT, et al.: Bradykinin induces eosinophil accumulation in the rat pleural cavity. Int Arch Allergy Appl Immunol 1991, 95:244-247.
47. Silva PM, Martins MA, Castro-Faria-Neto HC, et al.: Pleural eosinophil infiltration induced by PAF-acether is not a desensitizable phenomenon. Braz J Med Biol Res 1990, 23:1009-1013.